RxDoctor Payments Data

Michael Keller, DPM

Foot & Ankle Surgery · Kingston, NYNPI 1033186804

Payments from drug & device makers

What this record shows

This record is dominated by other: $512,430 of the $532,391 with a category attached, or 96.3%. Linvatec Corporation accounts for 96.6% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2022 at $454,982 and has fallen 99.6% since, to $1,921 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$532,391in general payments, 2019–2025

Across 156 payments — averaging $3412.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$514K
  • In2bones USA, LLC$4K
  • Seapearl East, Inc$4K
  • Stryker$3K
  • Arthrex$2K
  • Treace Medical Concepts, Inc.$969
  • plus $5K from 32 others

What the payments were for

  • Speaking & faculty fees$3,0001%
  • Grants$1,0000%
  • Travel & lodging$3,7621%
  • Food & beverage$7,7111%
  • Education$4,4881%
  • Other$512,43096%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$532,391 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$185,506
Medicare patients
694
Services billed
2,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox49$2,028
Diclofenac Sodium41$854
Ketoconazole14$365
Nabumetone34$205
Cefadroxil15$109
Methylprednisolone15$102
Doxycycline Monohydrate12$92
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$75

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Kingston

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →